EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Use this EXAS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the EXAS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the EXAS SEC filings page. Lician reads the product cache first so this HTML stays unique to EXACT Sciences Corporation even when a live quote feed is slow.
Latest cached year on this hub. Full EXAS income, balance, and cash tables.